Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Schnell, Matthias
Item TypeName
Concept Bacterial Vaccines
Concept Rabies Vaccines
Concept Vaccines, Attenuated
Concept Vaccines, Synthetic
Concept Viral Hepatitis Vaccines
Concept Viral Vaccines
Concept Vaccines, Inactivated
Concept AIDS Vaccines
Concept SAIDS Vaccines
Concept Cancer Vaccines
Concept Anthrax Vaccines
Concept Vaccines, Subunit
Concept Ebola Vaccines
Academic Article Characterization of a single-cycle rabies virus-based vaccine vector.
Academic Article Induction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathways.
Academic Article Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity.
Academic Article Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge.
Academic Article Rabies virus as a research tool and viral vaccine vector.
Academic Article Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.
Academic Article Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein.
Academic Article Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells.
Academic Article Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.
Academic Article New approaches to the development of live attenuated rabies vaccines.
Academic Article HIV-1 vaccines: the search continues.
Academic Article Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic.
Academic Article New approaches to the prevention and eradication of rabies.
Academic Article Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.
Academic Article Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases.
Academic Article In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife.
Academic Article Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque.
Academic Article Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach.
Academic Article The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines.
Academic Article A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.
Academic Article Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2.
Academic Article Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice.
Academic Article Immunogenicity of cytopathic and noncytopathic viral vectors.
Academic Article Rabies virus glycoprotein as a carrier for anthrax protective antigen.
Academic Article A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Academic Article Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
Academic Article Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus.
Academic Article Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.
Academic Article Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
Academic Article Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity.
Academic Article Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.
Academic Article Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge.
Academic Article Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics.
Grant Functional Analysis of NSV-based HIV vectors
Grant A novel rhabdovirus-based anthrax vaccine
Grant Prime/Boost Immunization against HIV-1 by Viral Vectors
Grant Rabies Virus-Based Vectors as an HIV-1 Vaccine
Grant Rabies Virus-Based Vectors as an HIV -1 Vaccine
Grant Development of a single-dose rabies virus vaccine
Grant Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
Grant Killed Rhabdoviruses as Novel Anthrax Vaccines
Academic Article Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens.
Grant Development of Rabies-based Virus-like Particles
Grant Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer
Academic Article Avoiding preventable deaths: The scourge of counterfeit rabies vaccines.
Academic Article Rabies-based vaccine induces potent immune responses against Nipah virus.
Academic Article Erratum: Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virus.
Grant Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
Grant Multivalent Tick-Microbe targeted Lyme disease vaccines
Academic Article Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2.
Academic Article Rhabdoviruses as vectors for vaccines and therapeutics.
Academic Article Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model.
Academic Article A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19.
Academic Article SARS-CoV-2 vaccines - the biggest medical research project of the 21st century.
Academic Article Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract.
Academic Article A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model.
Academic Article Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity.
Academic Article Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge.
Search Criteria
  • Vaccines